RAC 0.62% $1.62 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-170

  1. 1,526 Posts.
    lightbulb Created with Sketch. 379
    It sure was, so that data will be a massive help in getting to the FDA approval stage for US market from my understanding.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.